skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8847

Development of neurocognitive disorders in HIV/AIDS

Review

(1941) Views  (737) Full article downloads

Authors: Brandon C Dennis, Sidney A Houff, Dong Y Han, et al

Published Date March 2011 Volume 2011:3 Pages 9 - 18
DOI: http://dx.doi.org/10.2147/NBHIV.S7170

Brandon C Dennis1,2, Sidney A Houff1, Dong Y Han1, Frederick A Schmitt1,2,3
1Department of Neurology, 2Sanders-Brown Center on Aging, 3Departments of Psychiatry, Psychology, and Behavioral Science, University of Kentucky College of Medicine, Lexington, KY, USA

Abstract: The introduction of highly active antiretroviral therapy has had an enormous impact on the management of human immunodeficiency virus (HIV) infection and has led to an increase in survival and decrease in HIV-associated dementia. However, minor neurocognitive disturbances across various neurocognitive domains remain common in 50% or more of HIV patients according to recent estimates. Increased longevity has led to the investigation of several moderating and complicating factors, including vascular disease, neurotoxicity, aging, substance abuse, hepatitis C coinfection, and psychiatric illness. This article provides a review of the history of HIV-associated neurocognitive disorders (HAND), revised diagnostic terminology, factors moderating development of HAND, assessment techniques and neurocognitive profiles, current treatment and limitations, and future research directions.

Keywords: HIV-associated neurocognitive disorders, HIV dementia, AIDS dementia, AIDS







Readers of this article also read:

Depression care and prevalence in HIV-positive individuals
Impact of HIV infection and alcohol on cognition: a review
Cognitive function in treated HIV patients
Effect of older age at initiation of antiretroviral therapy on patient retention in an urban ART program in Uganda
Implementing the 2009 Institute of Medicine recommendations on resident physician work hours, supervision, and safety
A comparison of screening batteries in the detection of neurocognitive impairment in HIV-infected Spanish speakers
Cognitive reserve masks neurobehavioral expression of human immunodeficiency virus-associated neurological disorder in older patients
Stress management interventions for HIV-infected individuals: review of recent intervention approaches and directions for future research
Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine
Immune activation and neuropsychiatric symptoms in human immunodeficiency virus type 1 infection